(R,E)-4-(3-(2,5-difluorophenyl)allyl)-1-(3-(3-fluoro-6-methoxyquinolin-4-yl)propyl)piperazine-2-carboxylic acid

ID: ALA5178214

PubChem CID: 145147651

Max Phase: Preclinical

Molecular Formula: C27H28F3N3O3

Molecular Weight: 499.53

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc2ncc(F)c(CCCN3CCN(C/C=C/c4cc(F)ccc4F)C[C@@H]3C(=O)O)c2c1

Standard InChI:  InChI=1S/C27H28F3N3O3/c1-36-20-7-9-25-22(15-20)21(24(30)16-31-25)5-3-11-33-13-12-32(17-26(33)27(34)35)10-2-4-18-14-19(28)6-8-23(18)29/h2,4,6-9,14-16,26H,3,5,10-13,17H2,1H3,(H,34,35)/b4-2+/t26-/m1/s1

Standard InChI Key:  XSSZBMPRNHMAKY-VJZHMDQISA-N

Molfile:  

 
     RDKit          2D

 36 39  0  0  0  0  0  0  0  0999 V2000
   -5.0396    2.0787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0384    1.2537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3203    0.8385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6037    1.2507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6030    2.0800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8823    2.4960    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1647    2.0836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1599    1.2523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4395    0.8364    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8834    0.8346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8834    0.0028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1630   -0.4130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4425    0.0028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7221   -0.4130    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0017    0.0026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7159   -0.4126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7159   -1.2446    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4363   -1.6605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1566   -1.2446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8770   -1.6605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5975   -1.2446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5977   -0.4128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3163    0.0011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0370   -0.4148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0384   -1.2425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3210   -1.6623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.6598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7221   -1.2483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4425   -1.6642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1630   -1.2483    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4425   -2.4960    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7588    0.8378    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7588    0.0060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8772    0.0030    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.7588   -1.6584    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3257    2.4922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  4  3  1  0
  5  4  1  0
  6  5  2  0
  7  6  1  0
  8  7  2  0
  8  9  1  0
 10  8  1  0
  4 10  2  0
 11 10  1  0
 11 12  1  0
 12 13  1  0
 14 13  1  0
 15 14  1  0
 16 15  1  0
 17 16  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 22 21  2  0
 23 22  1  0
 24 23  2  0
 25 24  1  0
 26 25  2  0
 21 26  1  0
 27 17  1  0
 28 27  1  0
 14 28  1  0
 28 29  1  6
 29 30  1  0
 29 31  2  0
  2 32  1  0
 32 33  1  0
 22 34  1  0
 25 35  1  0
  1 36  2  0
  5 36  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5178214

    ---

Associated Targets(Human)

KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
gyrB DNA gyrase (1168 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
parC Topoisomerase IV (350 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
gyrB DNA gyrase (2092 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 499.53Molecular Weight (Monoisotopic): 499.2083AlogP: 4.38#Rotatable Bonds: 9
Polar Surface Area: 65.90Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 0.27CX Basic pKa: 8.46CX LogP: 2.22CX LogD: 2.19
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.47Np Likeness Score: -0.97

References

1. Flagstad T, Pedersen MT, Jakobsen TH, Felding J, Tolker-Nielsen T, Givskov M, Qvortrup K, Nielsen TE..  (2022)  Solid-phase synthesis and biological evaluation of piperazine-based novel bacterial topoisomerase inhibitors.,  57  [PMID:34906671] [10.1016/j.bmcl.2021.128499]

Source